Meikang Bio (300439.SZ) released its performance for the first three quarters, with net profit attributable to the parent company of 97.8377 million yuan, a year-on-year increase of 61.62%.

Zhitong Finance APP News, Meikang Bio (300439.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 1.274 billion yuan, a year-on-year increase of 12.22%. Net profit attributable to shareholders of the listed company was 97.8377 million yuan, a year-on-year increase of 61.62%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 80.3534 million yuan, a year-on-year increase of 157.49%.